TFF PharmaceuticalsTFFP
13F holders, Q2 2025 (June 30)1holders −2
0new positions
2sold out
$0.00avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding TFF Pharmaceuticals Inc. (TFFP) in their 13F filings, down 2 from Q1 2025. 0 opened new positions and 2 sold out. The largest holder was DRW Securities, LLC ($0).
- Company
- TFF Pharmaceuticals Inc.
- CUSIP
- 87241J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 115 shares sold, net −115 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| DRW Securities, LLC | 0.00% | No change | 40,000 | $0 |
"% of holder's portfolio" is TFFP's weight in each manager's 13F, not the share of TFF Pharmaceuticals Inc. the manager owns.